Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: A meta-analysis [1]

Journal of Thoracic Oncology

Volumn 3, Issue 3, 2008, Pages 320-

  Sculier, Jean Paul ^a   Meert, Anne Pascale ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; EPIRUBICIN; VINBLASTINE;

CANCER SURVIVAL; LETTER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 43249098533     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318166b833     Document Type: Letter

References (10)

1. M Baggstrom T Stinchombe D Fried C Poole T Hensing M Socinski Third generation chemotherapy agents in the treatment of advanced non small cell lung cancer J Thorac Oncol 2 2007 845 853
2. A Martoni M Guaraldi E Piana Multicenter randomized clinical trial on high-dose epirubicin plus cis- platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer Lung Cancer 22 1998 31 38
3. P Comella G Frasci N Panza Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the southern Italy cooperative oncology group J Clin Oncol 17 1999 1526 1534
4. M Perol JC Guerin P Thomas Multicenter randomized trial comparing cisplatin- mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. ‘Groupe Francais de Pneumo- Cancerologie' Lung Cancer 14 1996 119 134
5. JP Sculier JJ Lafitte J Lecomte A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer Ann Oncol 13 2002 874 882
6. S Danson MR Middleton KJ O'Byrne Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced non small cell lung carcinoma Cancer 98 2003 542 553
7. P Comella G Frasci G De Cataldis Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small- cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano Br J Cancer 74 1996 1805 1811
8. JF Vansteenkiste JE Vandebroek KL Nackaerts Clinical-benefit response in advanced non-small-cell lung cancer: a multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine Ann Oncol 12 2001 1221 1230
9. R Booton P Lorigan H Anderson A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1) Ann Oncol 17 2006 1111 1119
10. RM Rudd NH Gower SG Spiro Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group J Clin Oncol 23 2005 142 153